Novartis AG Issues $5.5 Billion in Notes Across Four Maturities

Novartis AG, through its subsidiary Novartis Capital Corporation, has announced the issuance of multiple tranches of notes totaling $5.5 billion. The notes include $500 million of 4.900% Notes due 2029, $1.5 billion of 5.200% Notes due 2032, $1.75 billion of 5.300% Notes due 2034, and $1.75 billion of 5.500% Notes due 2037. These issuances are being filed for incorporation into a Registration Statement on Form F-3.